Delivery Order SPE2DX22D0049-SPE2D825FB1LD
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $31,171.48 to AmerisourceBergen Drug Corp on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $54,374.70 to AmerisourceBergen Drug Corp on September 8, 2025, for pharmaceutical and medical supply products. This firm fixed-price, non-set-aside delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $1 billion ceiling through December 2026. The contract requires performance at the contractor's corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,838.53 to AmerisourceBergen Drug Corp on October 13, 2025, with an ultimate completion date of October 14, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to be delivered to the Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical and healthcare...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $87,605.42 to AmerisourceBergen Drug Corp on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $44,921.25 to AmerisourceBergen Drug Corp on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $42,468.57 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $272,697.60 to AmerisourceBergen Drug Corp on September 9, 2025, with completion targeted for September 10, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $54,074.37 to AmerisourceBergen Drug Corp on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,137.63 to AmerisourceBergen Drug Corp on August 21, 2025, with completion expected by August 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply operations. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen fulfills critical medical...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D825FB1LDDelivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $58,107.00 to AmerisourceBergen Drug Corp on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to be delivered to Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems, supplying a comprehensive portfolio of pharmaceutical products including brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. That prime contract vehicle serves as a global pharmaceutical support mechanism enabling the company to supply medical commodities to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates consistent capability in fulfilling open competitive procurements with firm fixed pricing across a wide range of medical supply values, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $58.1k | 9/22/25 |